Market Research Logo

Transplant Diagnostics: Technologies and Global Markets

Transplant Diagnostics: Technologies and Global Markets

The global transplant diagnostics market was valued at $512.3 million in 2015 and is estimated to grow at a CAGR of 9.8% from 2016 through 2021.

This report provides:
An overview of the global markets for transplant diagnostics.
Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Breakdowns of the market by application, end-users, and geography.
A look at how factors such as the high cost of instruments and limited insurance and reimbursement coverage available for transplant processes are expected to hamper the growth of the global transplant diagnostics market.
Evaluation of novel, future approaches in terms of biomarkers, bio-printing, and organoids.
Analyses of the market's dynamics: Drivers, restraints, opportunities.
Profiles of major players in the field.


SCOPE OF REPORT

The report covers the current market scenario for transplant diagnostics tests commercially available. These diagnostics tests are extensively used to study the compatibility between the donor and recipient in the process of organ transplantation. The report covers the segments mentioned below based on the revenue generated from the sales of transplant diagnostics products and services.

The following need to be taken into consideration:

The report considers the revenue generated by the sales of products, services and software used while conducting the transplant diagnostics test. These products can be kits, reagents, devices and software tools, among others.

The report considers revenue generated by pre-transplant as well as post-transplant tests. 

The report does not consider the revenue generated by carrying out blood tests prior to transplant procedures (which is minor and done along with counseling itself).

Although the report is closely associated with the organ transplant market, it does not consider any organ transplant cost in any manner. It only considers diagnostics. 

The periodic tests conducted post-transplant to determine the organ health in recipients’ bodies form a significant part of the revenue in the market.

The global transplant diagnostics market is segmented into two classes: nonmolecular assay and molecular assay technologies. Nonmolecular assay technologies are further segmented into serological assay and mixed lymphocyte culture (MLC) assay. The molecular assay technology market is segmented into polymerase chain reaction (PCR)-based and sequencing-based. The global transplant diagnostics technology market is further segmented on the basis of components for in-depth analysis of the market during the analysis period (2015-2021). The market study is detailed for the transplant diagnostics market based on end users as well as application area.

In-depth analysis of these segments is discussed in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies and regulatory scenario.

The market is segmented by region into North America, Europe, Asia-Pacific and ROW, including further division into key countries. Companies profiled in this report include Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Immucor Inc., Linkage Biosciences, Olerup SSP AB, Qiagen N.V., Thermo Fisher Scientific Inc. and Sigma-Aldrich, among others.

CHAPTER 1 INTRODUCTION
STUDY AND OBJECTIVE
SCOPE OF REPORT
INTENDED AUDIENCE
SOURCE OF INFORMATION AND METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR TRANSPLANT DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR TRANSPLANT DIAGNOSTICS BY REGION, 2015-2021 ($ MILLIONS)
CHAPTER 3 GLOBAL TRANSPLANT DIAGNOSTICS MARKET OVERVIEW
GLOBAL TRANSPLANT DIAGNOSTICS MARKET OVERVIEW
TABLE 1 TYPES OF ORGAN REJECTION POST-TRANSPLANT PROCEDURES
HLA TYPING IN TRANSPLANT DIAGNOSTICS
TABLE 2 MAJOR TYPES OF HUMAN LEUKOCYTE ANTIGEN
TABLE 3 LIST OF AUTOIMMUNE DISEASES LINKED WITH HLA TYPES
TABLE 4 LIST OF FEW HLA TESTS COMMERCIALLY AVAILABLE WITH CLINICAL
APPLICATIONS
MARKET EVOLUTION AND INNOVATIONS
NEXT-GENERATION SEQUENCING
PREPARATION OF LIBRARY
GENERATION OF CLUSTER
SEQUENCING OF THE FRAGMENTS
ANALYSIS OF THE DATA
GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, FOOD AND DRUG
ADMINISTRATION AND INTERNATIONAL REGULATORY AGENCIES
GOVERNMENT REGULATORY GUIDELINES FOR HLA TYPING
MEDICAL ASSOCIATIONS AND SOCIETIES FOR HLA TYPING
ROLE OF FDA IN TRANSPLANT DIAGNOSTICS
Laboratory-Developed Tests (LDTS)
Nucleic Acid-Based Tests
TABLE 5 NUCLEIC ACID TESTS APPROVED BY FDA DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES AND OTHER
PARAMETERS INFLUENCING MARKET GROWTH
NORTH AMERICA
FIGURE 1 NUMBER OF KIDNEY TRANSPLANTS IN NORTH AMERICA BY COUNTRY, 2015
FIGURE 2 NUMBER OF LIVER TRANSPLANTS IN NORTH AMERICA BY COUNTRY, 2015
FIGURE 3 NUMBER OF ORGAN DONATIONS IN NORTH AMERICA BY TYPE OF DONOR, 2015
FIGURE 4 NUMBER OF TRANSPLANTS BY TYPE OF ORGAN IN U.S., JANUARY 1988-JUNE 2016
FIGURE 5 TRANSPLANT PROCEDURES PERFORMED BY ORGAN TYPE IN U.S., JANUARY 1988-JUNE 2016 (%)
FIGURE 6 NUMBER OF TRANSPLANTS BY AGE OF RECIPIENT IN U.S., JANUARY 1988-JUNE 2016
FIGURE 7 NUMBER OF TRANSPLANTS BY TYPE OF DONOR IN U.S., 2011-2015
U.S. TRANSPLANT PROCEDURES
FIGURE 8 NUMBER OF ORGAN DONATIONS IN U.S. BY TYPE OF DONOR, 2015
FIGURE 9 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN U.S. BY TYPE OF ORGAN, 2015
CANADA TRANSPLANT PROCEDURES
FIGURE 10 NUMBER OF ORGAN DONATIONS IN CANADA BY TYPE OF DONOR, 2015
FIGURE 11 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN CANADA BY TYPE OF ORGAN, 2015
MEXICO TRANSPLANT PROCEDURES
FIGURE 12 NUMBER OF ORGAN DONATIONS IN MEXICO BY TYPE OF DONOR, 2015
FIGURE 13 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN MEXICO BY TYPE OF ORGAN, 2015
EUROPE
FIGURE 14 NUMBER OF KIDNEY TRANSPLANTS IN EUROPE BY COUNTRY, 2015
FIGURE 15 NUMBER OF LIVER TRANSPLANTS IN EUROPE BY COUNTRY, 2015
FIGURE 16 NUMBER OF ORGAN DONATIONS IN EUROPE BY TYPE OF DONOR, 2015
FIGURE 17 HYPERTENSIVE DISEASES IN EUROPE BY COUNTRY, 2015 (%)
FIGURE 18 NUMBER OF DEATHS CAUSED BY CIRCULATORY SYSTEM DISEASES IN EUROPE BY COUNTRY, 2012 (%)
FIGURE 19 NUMBER OF ORGAN DONATIONS BY TYPE OF DONOR IN EUROPE (FRANCE, GERMANY AND UNITED KINGDOM), JANUARY 1988-JUNE 2016
FIGURE 20 NUMBER OF TRANSPLANT PROCEDURES BY TYPE OF ORGAN IN EUROPE (FRANCE, GERMANY AND UNITED KINGDOM), JANUARY 1988-JUNE 2016
ASIA-PACIFIC
FIGURE 21 NUMBER OF KIDNEY TRANSPLANTS IN ASIA-PACIFIC BY COUNTRY, 2015
FIGURE 22 NUMBER OF LIVER TRANSPLANTS IN ASIA-PACIFIC BY COUNTRY, 2015
FIGURE 23 NUMBER OF LIVER TRANSPLANTS IN ASIA-PACIFIC BY COUNTRY AND TYPE OF DONOR, 2015
China's Transplant Procedures
FIGURE 24 NUMBER OF ORGAN/TISSUE TRANSPLANT PROCEDURES BY TYPE OF DONOR IN HONG KONG, 2015
Japan Transplant Procedures
FIGURE 25 NUMBER OF ORGAN TRANSPLANTS FROM DECEASED DONORS BY TYPE OF ORGAN IN JAPAN, 2015
Australia Transplant Procedures
FIGURE 26 NUMBER OF ORGAN DONATIONS BY TYPE OF DONOR IN AUSTRALIA, 2015
FIGURE 27 NUMBER OF ORGAN TRANSPLANTS BY TYPE OF ORGAN IN AUSTRALIA, 2015
FIGURE 28 NUMBER OF TISSUE TRANSPLANT PROCEDURES BY TYPE OF TISSUE IN AUSTRALIA, 2015
India Transplant Procedures
ROW
CLINICAL GUIDELINES AND REIMBURSEMENT SCENARIO
GUIDELINES FOR TRANSPLANT DIAGNOSTICS
REIMBURSEMENT SCENARIO FOR TRANSPLANT DIAGNOSTICS
TABLE 6 LIST OF CPT CODES FOR HLA TYPING WITH SEROLOGICAL
TESTING
TABLE 7 MAXIMUM FEES FOR PATHOLOGY LABORATORY, ON AND AFTER JANUARY 1, 2015 ($)
TECHNOLOGY TRENDS
NOVEL INNOVATIONS FOR FUTURE OF TRANSPLANT DIAGNOSTICS
Biomarkers
TABLE 8 LABORATORY-BASED PRE-TRANSPLANTATION BIOMARKERS
TABLE 9 LABORATORY-BASED POST-TRANSPLANTATION BIOMARKERS (ACUTE ALLOGRAFT REJECTION)
TABLE 10 LABORATORY-BASED POST-TRANSPLANTATION BIOMARKERS (CHRONIC ALLOGRAFT DAMAGE)
TABLE 11 LABORATORY-BASED POST-TRANSPLANTATION BIOMARKERS (ALLOGRAFT ACCOMMODATION)
TABLE 12 FDA-APPROVED BIOMARKERS
Bioprinting
TABLE 13 MATERIALS USED FOR BIOPRINTING
Organoids
TABLE 14 APPLICATION OF ORGANOIDS BY TYPE
Organoids in Transplant Diagnostics
U.S. HIV ORGAN POLICY EQUITY (HOPE) ACT, 2013
FIGURE 29 HISTORY OF THE HOPE ACT, 2013
ELIGIBILITY CRITERIA FOR HIV-POSITIVE DONORS AND RECIPIENTS
Eligibility Criteria for HIV-Positive Living Donors
Eligibility Criteria for HIV-Positive Deceased Donors
Eligibility Criteria for HIV-Positive Recipients
Transplant Hospital Criteria
Independent Advocates for HIV-Positive Living Organ Donor and
Recipient
Responsibilities of the Independent HIV-Positive Recipient Advocate
Responsibilities of the Independent HIV-Positive Donor Advocate
Bio Specimens
KEY STRATEGIES
FIGURE 30 MAJOR STRATEGIES ADOPTED BY PLAYERS IN THE TRANSPLANT
DIAGNOSTICS MARKET
TABLE 15 STRATEGIC DEVELOPMENT IN TRANSPLANT DIAGNOSTICS MARKET, 2012-2016 (NO./%)
TABLE 16 FDA APPROVALS FOR TRANSPLANT DIAGNOSTICS PRODUCTS, 2013-2016
TABLE 17 CE APPROVALS FOR TRANSPLANT DIAGNOSTICS PRODUCTS, 2013-2016
TABLE 18 NEW PRODUCT LAUNCHES IN TRANSPLANT DIAGNOSTICS MARKET, 2013-2016
TABLE 19 COMPANIES ADOPTING M &A AS A DEVELOPMENTAL STRATEGY IN TRANSPLANT DIAGNOSTICS MARKET
TABLE 20 MERGERS AND ACQUISITIONS IN THE TRANSPLANT DIAGNOSTICS MARKET, 2012-2016
TABLE 21 COMPANIES ADOPTING AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS AS A DEVELOPMENTAL STRATEGY IN TRANSPLANT DIAGNOSTICS MARKET, 2012-2016
TABLE 22 LIST OF COMPANIES THAT ADOPTED AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS AS KEY STRATEGY,2012-2016
TABLE 23 COMPANIES ADOPTING EXPANSION AS A KEY STRATEGY IN TRANSPLANT DIAGNOSTICS MARKET, 2011-2016
TABLE 24 COMPANIES ADOPTING INVESTMENT AS A KEY STRATEGY IN TRANSPLANT DIAGNOSTICS MARKET, 2013-2016
MARKET DYNAMICS
DRIVERS
Increasing Geriatric Population
FIGURE 31 GLOBAL POPULATION AGED 60 AND OVER BY REGION, 2015 (NO.)
Rising Chronic Diseases
TABLE 25 CHRONIC DISEASES LISTED BY THE WHO, 2010-2013
Increased Research and Development
TABLE 26 PRODUCT LAUNCHES IN TRANSPLANT DIAGNOSTICS MARKET, 2012-2016
RESTRAINTS
Challenges in HLA Sequencing
Demand and Supply Gap
FIGURE 32 WAITING LIST FOR ORGANS IN U.S. BY TYPE OF ORGAN AS OF JULY 15, 2016 (NO.)
FIGURE 33 WAITING LIST FOR ORGANS IN U.S. BY AGE OF DONOR AS OF JULY 15, 2016 (NO.)
OPPORTUNITIES
Increasing Need for Organ Transplants
Shift from Traditional Serological Typing to Gene-based HLA Typing
CHAPTER 4 TRANSPLANT DIAGNOSTICS MARKET ANALYSIS BY
TECHNOLOGIES
TABLE 27 GLOBAL MARKET FOR TRANSPLANT DIAGNOSTICS BY TECHNOLOGIES, THROUGH 2021 ($ MILLIONS)
MOLECULAR ASSAY TECHNOLOGIES
TABLE 28 GLOBAL MARKET FOR MOLECULAR ASSAYS BY TYPE, THROUGH 2021 ($ MILLIONS)
TABLE 29 GLOBAL MARKET FOR MOLECULAR ASSAY BY REGION, THROUGH 2021 ($ MILLIONS)
PCR-BASED MOLECULAR ASSAY
TABLE 30 GLOBAL MARKET FOR PCR-BASED MOLECULAR ASSAYS BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 34 WORKFLOW FOR POLYMERASE CHAIN REACTION
PCR-Sequence Specific Primer (SSP)
PCR Sequence-Specific Oligonucleotide (SSO)
SEQUENCING-BASED MOLECULAR ASSAY
TABLE 31 GLOBAL MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS BY REGION, THROUGH 2021 ($ MILLIONS)
Sanger Sequencing
Next-Generation Sequencing
TABLE 32 COMPARISON OF NGS PLATFORMS
NONMOLECULAR ASSAY TECHNOLOGIES
TABLE 33 GLOBAL MARKET FOR NONMOLECULAR ASSAYS BY TYPE, THROUGH 2021 ($ MILLIONS)
TABLE 34 GLOBAL MARKET FOR NONMOLECULAR ASSAYS BY REGION, THROUGH 2021 ($ MILLIONS)
SEROLOGICAL ASSAYS
TABLE 35 GLOBAL MARKET FOR SEROLOGICAL ASSAYS BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 36 SEROLOGICAL TYPES AND THEIR SENSTIVITY FOR ANTIBODY DETECTION (MCG/ML)
MIXED LYMPHOCYTE CULTURE ASSAYS
TABLE 37 GLOBAL MARKET FOR MLC ASSAYS, BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 5 BY COMPONENT
TABLE 38 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY COMPONENT, THROUGH 2021 ($ MILLIONS)
TABLE 39 GLOBAL TRANSPLANT DIAGNOSTICS COMPONENT MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
INSTRUMENTS
TABLE 40 GLOBAL TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
SEQUENCING SYSTEMS
READER/ANALYZER INSTRUMENTS
AUTOMATED DISPENSERS
NGS INSTRUMENTS
TABLE 41 LIST OF FEW COMMERCIALLY AVAILABLE INSTRUMENTS FOR TRANSPLANT DIAGNOSTICS
REAGENTS AND CONSUMABLES
TABLE 42 GLOBAL TRANSPLANT DIAGNOSTICS REAGENTS AND CONSUMABLES MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
CYTOTOXIC CONTROLS
B27 MONOCLONAL ANTIBODIES
BULK MONOCLONAL ANTIBODIES
FLUOROBEADS ISOLATION REAGENTS
STAINING/QUENCHING REAGENTS
ISOLATION REAGENTS
POOLED HUMAN SERUM (PHS)
RABBIT COMPLEMENT
STAIN-FIXATION REAGENTS
SEROLOGICAL TYPING REAGENTS FOR HLA TYPING
TABLE 43 LIST OF COMMERCIALLY AVAILABLE REAGENTS FOR TRANSPLANT DIAGNOSTICS
SOFTWARE AND SERVICES
TABLE 44 GLOBAL TRANSPLANT DIAGNOSTICS SOFTWARE AND SERVICES MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 45 LIST OF COMMERCIALLY AVAILABLE SOFTWARE AND SERVICES FOR TRANSPLANT DIAGNOSTICS
CHAPTER 6 TRANSPLANT DIAGNOSTICS MARKET ANALYSIS BY END USER
TABLE 46 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY END USER, THROUGH 2021 ($ MILLIONS)
TABLE 47 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
HOSPITALS AND TRANSPLANT CENTERS
TABLE 48 GLOBAL TRANSPLANT DIAGNOSTICS HOSPITALS AND
TRANSPLANT CENTERS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
TABLE 49 HOSPITALS PROVIDING HLA TYPING AND TRANSPLANT SERVICES
RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS
TABLE 50 GLOBAL TRANSPLANT DIAGNOSTICS RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
COMMERCIAL SERVICE PROVIDERS
TABLE 51 GLOBAL TRANSPLANT DIAGNOSTICS COMMERCIAL SERVICE PROVIDERS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 7 TRANSPLANT DIAGNOSTICS MARKET ANALYSIS BY
APPLICATIONS
TABLE 52 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY APPLICATIONS, THROUGH 2021 ($ MILLIONS)
TABLE 53 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
RESEARCH
TABLE 54 GLOBAL TRANSPLANT DIAGNOSTICS RESEARCH MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
BLOOD AND MARROW TRANSPLANT PROGRAMS
HEART/LUNG TRANSPLANTATION
TABLE 55 SURVIVAL RATES OF PATIENTS
DIAGNOSTICS
TABLE 56 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 8 COMPETITIVE LANDSCAPE
COMPETITIVE LANDSCAPE
TABLE 57 KEY COMPETITIVE STRATEGIES, 2012-2016 (NO./%)
PRODUCT APPROVALS AND LAUNCHES
TABLE 58 PRODUCT APPROVAL AND LAUNCH STRATEGY BY COMPANY, 2013-2016 (NO./%)
TABLE 59 LIST OF KEY PRODUCT APPROVALS AND LAUNCHES ANNOUNCED, 2013-2016
MERGERS AND ACQUISITIONS
TABLE 60 MERGER AND ACQUISITION STRATEGY BY COMPANIES, 2012-2016 (NO./%)
TABLE 61 LIST OF KEY MERGERS AND ACQUISITIONS ANNOUNCED, 2013-2016
AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
TABLE 62 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS STRATEGY BY COMPANIES, 2012-2016 (NO./%)
TABLE 63 LIST OF KEY AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS ANNOUNCED, 2012-2016
EXPANSION
TABLE 64 EXPANSION STRATEGIES BY COMPANIES, 2011-2016 (NO./%)
TABLE 65 LIST OF KEY EXPANSIONS ANNOUNCED, 2011-2016
INVESTMENTS
TABLE 66 INVESTMENTS STRATEGY BY COMPANIES, 2012-2016 (NO./%)
TABLE 67 LIST OF KEY INVESTMENTS ANNOUNCED, 2012-2016
CHAPTER 9 REGIONAL ANALYSIS
TABLE 68 GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
NORTH AMERICA
TABLE 69 NORTH AMERICAN TRANSPLANT DIAGNOSTIC MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
TABLE 70 NORTH AMERICAN TRANSPLANT DIAGNOSTIC MARKET BY END USER, THROUGH 2021 ($ MILLIONS)
TABLE 71 COMMERCIAL TRANSPLANT DIAGNOSTICS PRODUCTS
APPROVED BY THE FDA
TABLE 72 MAJOR TRANSPLANT DIAGNOSTICS COMPANIES BASED IN THE UNITED STATES
EUROPE
TABLE 73 EUROPEAN TRANSPLANT DIAGNOSTIC MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
TABLE 74 EUROPEAN TRANSPLANT DIAGNOSTIC MARKET BY END USER, THROUGH 2021 ($ MILLIONS)
SPAIN
TABLE 75 NUMBER OF ORGAN DONATIONS IN SPAIN BY TYPE OF DONOR, 2014
TABLE 76 NUMBER OF ORGAN TRANSPLANTS IN SPAIN BY TYPE OF ORGAN, 2014
ITALY
TABLE 77 NUMBER OF ORGAN TRANSPLANTS IN ITALY BY TYPE OF ORGAN, 2015
TABLE 78 NUMBER OF ORGAN DONATIONS IN ITALY BY TYPE OF DONOR, 2015
TURKEY
TABLE 79 NUMBER OF ORGAN DONATIONS IN TURKEY BY TYPE OF DONOR, 2015
TABLE 80 NUMBER OF ORGAN TRANSPLANTS IN TURKEY BY TYPE OF ORGAN, 2015
TABLE 81 CE APPROVAL FOR TRANSPLANT DIAGNOSTICS MARKET
TABLE 82 MAJOR EUROPEAN PLAYERS IN TRANSPLANT DIAGNOSTICS
MARKET
ASIA-PACIFIC
TABLE 83 ASIA-PACIFIC TRANSPLANT DIAGNOSTIC MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
TABLE 84 ASIA-PACIFIC TRANSPLANT DIAGNOSTIC MARKET BY END USER, THROUGH 2021 ($ MILLIONS)
MALAYSIA
TABLE 85 NUMBER OF ORGAN DONATIONS IN MALAYSIA BY TYPE OF DONOR, 2013
TABLE 86 NUMBER OF ORGAN TRANSPLANTS IN MALAYSIA BY TYPE OF ORGAN, 2013
NEW ZEALAND
TABLE 87 NUMBER OF ORGAN DONATIONS IN NEW ZEALAND BY TYPE OF DONOR, 2015
TABLE 88 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN NEW ZEALAND BY TYPE OF ORGAN, 2015
TABLE 89 TRANSPLANT DIAGNOSTICS COMPANY PRESENT IN ASIA
REST OF THE WORLD
TABLE 90 ROW TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS)
TABLE 91 ROW TRANSPLANT DIAGNOSTICS MARKET BY END USER,
THROUGH 2021 ($ MILLIONS)
BRAZIL
TABLE 92 COMMUNICABLE AND NONCOMMUNICABLE DISEASES
LEADING TO MORTALITY IN BRAZIL, 2014 (%)
TABLE 93 NUMBER OF ORGAN DONATIONS IN BRAZIL BY TYPE OF DONOR, 2015
TABLE 94 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN BRAZIL BY TYPE OF ORGAN, 2015
ISRAEL
TABLE 95 AGE ADJUSTED HOSPITALIZATION RATE DUE TO CHRONIC DISEASES IN ISRAEL, 2013 (PER 100,000 ABOVE 15 YEARS)
TABLE 96 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN ISRAEL BY TYPE OF ORGAN, 2015
TABLE 97 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN ISRAEL BY TYPE OF ORGAN, 2015
IRAN
TABLE 98 NUMBER OF ORGAN DONATIONS IN IRAN BY TYPE OF DONOR, 2015
TABLE 99 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN IRAN BY TYPE OF ORGAN, 2015
TABLE 100 NUMBER OF TISSUE TRANSPLANT PROCEDURES IN IRAN BY TYPE OF TISSUE, 2015
SAUDI ARABIA
TABLE 101 NUMBER OF ORGAN DONATIONS IN SAUDI ARABIA BY TYPE OF DONOR, 2015
TABLE 102 NUMBER OF ORGAN TRANSPLANT PROCEDURES IN SAUDI
ARABIA BY TYPE OF ORGAN, 2015
CHAPTER 10 PATENT ANALYSIS
INTRODUCTION
TABLE 103 PATENTS REGISTERED/APPROVED BY COUNTRY, 2010-2016 (NO./%)
FIGURE 35 PATENTS REGISTERED/APPROVED BY COUNTRY, 2010-2016 (%)
UNITED STATES
TABLE 104 PATENTS REGISTERED/APPROVED IN U.S. BY TYPE OF PRODUCT, 2010-2016 (NO./%)
FIGURE 36 PATENTS REGISTERED/APPROVED IN U.S. BY TYPE OF PRODUCT, 2010-2016 (%)
CHINA
TABLE 105 PATENTS REGISTERED/APPROVED IN CHINA BY TYPE OF PRODUCT, 2010-2016 (NO./%)
FIGURE 37 PATENTS REGISTERED/APPROVED IN CHINA BY TYPE OF PRODUCT, 2010-2016 (%)
EUROPE
TABLE 106 PATENTS REGISTERED/APPROVED BY MARKET PARTICIPANTS, 2010-2016 (NO./%)
TABLE 107 PATENTS REGISTERED/APPROVED BY MARKET PARTICIPANTS, 2010-2016
FIGURE 38 PATENTS REGISTERED/APPROVED BY MARKET PARTICIPANTS, 2010-2016 (%)
TABLE 108 PATENTS REGISTERED/APPROVED BY TYPE OF PRODUCT, 2010-2016 (NO./%)
FIGURE 39 PATENTS REGISTERED/APPROVED BY TYPE OF PRODUCT, 2010-2016 (%)
TABLE 109 PATENTS RELATED TO TRANSPLANTS
CHAPTER 11 COMPANY PROFILES
ABBOTT LABORATORIES
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 110 RECENT DEVELOPMENTS OF ABBOTT LABORATORIES
ABBOTT LABORATORIES FINANCIALS
TABLE 111 ABBOTT LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%)
AFFYMETRIX INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 112 RECENT DEVELOPMENTS OF AFFYMETRIX INC.
AFFYMETRIX INC. FINANCIALS
TABLE 113 AFFYMETRIX INC. FINANCIALS, 2012-2014 ($ MILLIONS/%)
ASTELLAS PHARMA INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
ASTELLAS PHARMA INC. FINANCIALS
TABLE 114 ASTELLAS PHARMA INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
BIOFORTUNA LTD.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 115 RECENT DEVELOPMENTS OF BIOFORTUNA LTD.
BIOFORTUNA LTD. FINANCIALS
TABLE 116 BIOFORTUNA LTD. FINANCIALS, 2013-2015 ($ MILLIONS/%)
BIO-RAD LABORATORIES
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 117 RECENT DEVELOPMENTS OF BIO-RAD LABORATORIES
BIO-RAD LABORATORIES FINANCIALS
TABLE 118 BIO-RAD LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%)
CAREDX INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 119 RECENT DEVELOPMENTS OF CAREDX INC.
CAREDX INC. FINANCIALS
TABLE 120 CAREDX INC. FINANCIALS, 2012-2014 ($ MILLIONS/%)
DIASORIN S.P.A.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 121 RECENT DEVELOPMENTS OF DIASORIN S.P.A.
FINANCIALS
TABLE 122 DIASORIN S.P.A. FINANCIALS, 2013-2015 ($ MILLIONS/%)
F. HOFFMANN-LA ROCHE AG
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 123 RECENT DEVELOPMENTS OF F. HOFFMANN-LA ROCHE AG
F. HOFFMANN-LA ROCHE AG FINANCIALS
TABLE 124 F. HOFFMANN-LA ROCHE AG FINANCIALS, 2013-2015 ($ MILLIONS/%)
FUJIREBIO EUROPE N.V.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
GENDX (GENOME DIAGNOSTICS B.V.)
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 125 RECENT DEVELOPMENTS OF GENDX
ILLUMINA INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 126 RECENT DEVELOPMENTS OF ILLUMINA INC.
ILLUMINA INC. FINANCIALS
TABLE 127 ILLUMINA INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
IMMUCOR INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 128 RECENT DEVELOPMENTS OF IMMUCOR INC.
IMMUCOR INC. FINANCIALS
TABLE 129 IMMUCOR INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
LINKAGE BIOSCIENCES
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 130 RECENT DEVELOPMENTS OF LINKAGE BIOSCIENCES
LUMINEX CORP.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 131 RECENT DEVELOPMENTS OF LUMINEX CORP.
LUMINEX CORP. FINANCIALS
TABLE 132 LUMINEX CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
OLERUP SSP AB
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 133 RECENT DEVELOPMENTS OF OLERUP SSP AB
OMIXON BIOCOMPUTING LTD.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
QIAGEN N.V.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 134 RECENT DEVELOPMENTS OF QIAGEN N.V.
QIAGEN N.V. FINANCIALS
TABLE 135 QIAGEN N.V. FINANCIALS, 2013-2015 ($ MILLIONS/%)
SIGMA-ALDRICH CORP.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
SIGMA-ALDRICH FINANCIALS
TABLE 136 SIGMA-ALDRICH FINANCIALS, 2013-2015 ($ MILLIONS/%)
THERMO FISHER SCIENTIFIC INC.
TRANSPLANT DIAGNOSTICS PRODUCT PORTFOLIO
RECENT DEVELOPMENTS
TABLE 137 RECENT DEVELOPMENTS OF THERMO FISHER SCIENTIFIC INC.
THERMO FISHER SCIENTIFIC FINANCIALS
TABLE 138 THERMO FISHER SCIENTIFIC FINANCIALS, 2013-2015 ($ MILLIONS/%)
TRANSPLANT GENOMICS INC.
RECENT DEVELOPMENTS
TABLE 139 RECENT DEVELOPMENTS OF TRANSPLANT GENOMICS INC.
CHAPTER 12 APPENDIX
TABLE 140 LIST OF PATENTS ISSUED IN CANADA
TABLE 141 LIST OF PATENTS ISSUED IN CHINA
TABLE 142 LIST OF PATENTS IN ISSUED EUROPE (WO)
TABLE 143 LIST OF PATENTS ISSUED IN EUROPE
TABLE 144 LIST OF PATENTS ISSUED BY THE EUROPEAN PATENT OFFICE (EPO)
TABLE 145 LIST OF PATENTS ISSUED IN JAPAN
TABLE 146 LIST OF PATENTS ISSUED IN KOREA
TABLE 147 LIST OF PATENTS ISSUED IN THE RUSSIAN FEDERATION
TABLE 148 LIST OF PATENTS ISSUED IN SINGAPORE

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report